Advances in Analytical Strategies for Precise Quantification of Topoisomerase Inhibitors: Current Trends and Future Directions
- 20 February 2026
- journal article
- review article
- Published by Wiley in Biomedical Chromatography
- Vol. 40 (4) , e70386
Abstract
Topoisomerase inhibitors (TIs) are a cornerstone class of anticancer and antimicrobial agents, yet their accurate quantification in pharmaceutical formulations and biological matrices remains analytically challenging. These difficulties stem from marked structural diversity, poor aqueous solubility, narrow therapeutic windows, very low circulating concentrations, chemical instability, and, for camptothecin derivatives, pH‐dependent interconversion between active lactone and inactive carboxylate forms. This review critically evaluates current analytical approaches for determining widely used TIs, including topotecan, irinotecan, etoposide, epirubicin, dexrazoxane, and camptothecin, with emphasis on selectivity, sensitivity, applicability, and robustness in complex matrices. Conventional spectroscopic methods and HPLC with UV or fluorescence detection remain useful for formulation analysis and preliminary screening but often lack sufficient selectivity and sensitivity for biological samples. Electrochemical techniques, especially those employing nanomaterials or molecular recognition elements, offer high sensitivity and low sample consumption; however, their routine application is limited by matrix effects and scarce regulatory validation. In contrast, ultrahigh‐performance liquid chromatography coupled with tandem or high‐resolution mass spectrometry (UHPLC–MS/MS or UHPLC–HRMS) provides superior selectivity, sub‐ng mL −1 sensitivity, and reliable discrimination of parent drugs and metabolites across diverse matrices. Overall, UHPLC–MS‐based methods emerge as the current gold standard for TI quantification, supporting clinical, pharmacokinetic, and regulatory applications in modern analytical science.Keywords
This publication has 210 references indexed in Scilit:
- Simultaneous determination of camptothecin and 10‐hydroxycamptothecine in the Camptotheca acuminate, its medicinal preparation and in rat plasma by liquid chromatography with fluorescence detectionBiomedical Chromatography, 2015
- HPLC‐UV method for quantifying etoposide in plasma and tumor interstitial fluid by microdialysis: application to pharmacokinetic studiesBiomedical Chromatography, 2014
- A rapid, simple and reliable HPLC‐triple quadrupole tandem mass spectrometer method for a simultaneous quantification of irinotecan and its active metabolite 7‐ethyl‐10‐hydroxycamptothecin (SN38) in mouse plasmaBiomedical Chromatography, 2014
- Development and validation of a liquid chromatography–tandem mass spectrometry method for topotecan determination in beagle dog plasma and its application in a bioequivalence studyBiomedical Chromatography, 2013
- An HPLC assay for the lipophilic camptothecin analog AR‐67 carboxylate and lactone in human whole bloodBiomedical Chromatography, 2010
- Application of a highly specific and sensitive fluorescent HPLC method for topotecan lactone in whole bloodBiomedical Chromatography, 2009
- Dodging matrix effects in liquid chromatography tandem mass spectrometric assays—compilation of key learnings and perspectivesBiomedical Chromatography, 2008
- An analytical method for irinotecan (CPT‐11) and its metabolites using a high‐performance liquid chromatography: parallel detection with fluorescence and mass spectrometryBiomedical Chromatography, 2002
- High-throughput quantitative bioanalysis by LC/MS/MSBiomedical Chromatography, 2000
- Rapid quantitative determination of epirubicin and its metabolites in plasma using high performance liquid chromatography and fluorescence detectionBiomedical Chromatography, 1990